Spanish investment firms Asabys Partners and Aliath Bioventures have merged in a strategic consolidation, elevating Asabys' assets under management from $351 million to over $468 million. This partnership aims to build a €1 billion-plus life sciences investment platform by 2030, targeting early-stage to growth healthcare investments across biopharma, medtech, and digital health. The integration combines complementary investment approaches and enhances capacity to support healthcare innovation and company formation throughout Europe.